MoneyWorks4Me

Suven Pharmaceuticals informs about credit rating

28 Feb 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Suven Pharmaceuticals has informed that the CRISIL has assigned/ reaffirmed the ratings to the Bank facilities of the Company as per letter received on February 28, 2025. The said letter is annexed.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..